SCHEMBL759491

SCHEMBL759491

CNC(=S)NN=C(C)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 1.00
TDP1 Q9NUW8 3/20 1.00
NPSR1 Q6W5P4 2/20 1.00
ALOX12 P18054 4/20 0.66
MAPT P10636 4/20 0.66
ATM Q13315 1/20 0.66
METTL3 Q86U44 1/20 0.66
POLB P06746 1/20 0.65
LMNA P02545 5/20 0.64
ALDH1A1 P00352 6/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
KDM4E B2RXH2 2/20 0.62
NFKB1 P19838 1/20 0.62
OPRK1 P41145 1/20 0.62
NFKB2 Q00653 1/20 0.62
RELA Q04206 1/20 0.62
TOP2A P11388 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
RAB9A P51151 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15672271 1.00 GAA (1.00) GAATDP1NPSR1ALOX12MAPT
SCHEMBL13002923 0.82 GAA (0.70) GAATDP1NPSR1ALOX12MAPT
SCHEMBL942900 0.81 TDP1 (0.68) GAATDP1NPSR1ALOX12MAPT
SCHEMBL27614860 0.81 TDP1 (0.72) GAATDP1NPSR1ALOX12MAPT
SCHEMBL20777001 0.81 GAA (0.68) GAATDP1NPSR1ALOX12MAPT
SCHEMBL21761708 0.80 GAA (0.66) GAATDP1NPSR1ALOX12MAPT
Acetophenone-Thiosemicarbazone SCHEMBL17666972 0.79 METTL3 (1.00) ATMMETTL3LMNAALDH1A1
Phenyl(Methyl)Thiosemicarbazone SCHEMBL14436799 0.79 METTL3 (1.00) ATMMETTL3LMNAALDH1A1
Phenyl(Methyl)Thiosemicarbazone SCHEMBL757506 0.79 METTL3 (1.00) ATMMETTL3LMNAALDH1A1
SCHEMBL28758619 0.79 GAA (0.65) GAATDP1NPSR1ALOX12MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318782-B2 Mitotic kinesin inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-11-27 US disclosed
EP-1847534-B9 Thiadiazoline derivatives for treating cancer KYOWA HAKKO KIRIN CO LTD (JP) 2012-03-21 EP disclosed
US-20110275827-A1 Mitotic Kinesin Inhibitor FUJIFILM CORPORATION (JP) 2011-11-10 US disclosed
EP-1454903-B9 Thiadiazoline derivatives for treating cancer KYOWA HAKKO KIRIN CO LTD (JP) 2011-10-05 EP disclosed
EP-1847534-B1 Thiadiazoline derivatives for treating cancer KYOWA HAKKO KIRIN CO LTD (JP) 2011-06-22 EP disclosed
EP-2327702-A1 Mitotic kinesin inhibitor Kyowa Hakko Kirin Co., Ltd. (JP) 2011-06-01 EP disclosed
US-7902234-B2 Thiadiazoline derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-03-08 US disclosed
US-20110004000-A1 Mitotic Kinesin Inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-01-06 US disclosed
US-7851635-B2 Mitotic kinesin inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-12-14 US disclosed
US-20100240716-A1 THIADIAZOLINE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-09-23 US disclosed
CN-100484928-C thiadiazoline derivatives KYOWA HAKKO KOGYO KK FUJI PHOT (JP) 2009-05-06 CN disclosed
US-7425636-B2 Thiadiazoline derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-09-16 US disclosed
US-20080207706-A1 THIADIAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD (JP) 2008-08-28 US disclosed
EP-1847534-A2 Thiadiazoline derivative Kyowa Hakko Kogyo Co., Ltd (JP) 2007-10-24 EP disclosed
US-20070213380-A1 Thiadiazoline derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-09-13 US disclosed
US-20070155804-A1 Mitotic kinesin inhibitor KYOWA HAKKO KOGYO CO., LTD. OF TOKYO, JAPAN FUJI PHOTO FILM CO., LTD. KANAGAWA, JAPAN 2007-07-05 US disclosed
US-20060074113-A1 Thiadiazoline derivative KYOWA KIRIN CO., LTD. (JP) 2006-04-06 US disclosed
EP-1616866-A1 M-STAGE KINESIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-01-18 EP disclosed
CN-1617864-A thiadiazoline derivatives KYOWA HAKKO KOGYO KK (JP) 2005-05-18 CN disclosed
EP-1454903-A1 THIADIAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074113-A1 Thiadiazoline derivative BRWD1, RB1, ARG2 GAA 4130/4885TDP1 1546/4885NPSR1 3376/4885
US-20070155804-A1 Mitotic kinesin inhibitor KIF15, KIF5A, KIF5B GAA 1882/4885TDP1 1281/4885NPSR1 4589/4885
US-20070213380-A1 Thiadiazoline derivative BRWD1, RB1, ARG2 GAA 4130/4885TDP1 1546/4885NPSR1 3376/4885
US-20110004000-A1 Mitotic Kinesin Inhibitor KIF15, KIF5A, KIF5B GAA 1882/4885TDP1 1281/4885NPSR1 4589/4885
US-20100240716-A1 THIADIAZOLINE DERIVATIVE BRWD1, WDR82, RB1 GAA 3801/4885TDP1 1533/4885NPSR1 3776/4885
US-20080207706-A1 THIADIAZOLINE DERIVATIVE BRWD1, RB1, ARG2 GAA 4130/4885TDP1 1546/4885NPSR1 3376/4885
US-20110275827-A1 Mitotic Kinesin Inhibitor KIF15, KIF5A, KIF5B GAA 1882/4885TDP1 1281/4885NPSR1 4589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.